From: Significance of serum Myostatin in hemodialysis patients
 | Total population |
---|---|
N | 37 |
Gender (M/F) | 23/14 |
Age, (years) | 69.6 ± 15 |
BMI, (kg/m2) | 26.4 ± 4.2 |
Diabetes, n (%) | 12 (32) |
Time on dialysis, months (IQR) | 35 (19.5–48) |
Type of dialysis, n (%) | |
BHD, n (%) | 24 (65) |
HDF, n (%) | 13 (35) |
Serum potassium (mEq/L) | 4.6 ± 0.7 |
Serum albumin (g/L) | 32 ± 0.4 |
Prealbumin (g/L) | 0.3 ± 0.08 |
Total cholesterol (mmol/L) | 3.6 ± 0.9 |
Triglycerides (mmol/L) | 1.8 ± 0.8 |
Phosphate (mmol/L) | 1.6 ± 0.5 |
McAuley index | 5.6 ± 2 |
CRP (mg/dl), IQR | 0.76 (0.25–1.2) |
Transferrin (g/L) | 1.7 ± 0.3 |
spKT/V | 1.66 ± 0.3 |